Hospital Infections by Antimicrobial-Resistant Organisms in Developing Countries

  • Fatima Mir
  • Anita K. M. Zaidi


Antimicrobial resistance is a global public health concern. Hospitals in developing countries are fighting a progressively uphill battle against not only high burden of infectious diseases but also an ever-increasing proportion of multidrug-resistant pathogens. As many as 56% of Staphylococcus aureus isolates from hospital-acquired infections in South Asia have now become methicillin resistant. Vancomycin-resistant enterococci (VRE), with a reported prevalence of 6–12% in Asian hospital-based studies account for 10% of nosocomial urinary tract infections and a 31% mortality rate with VRE bacteremias. Third-generation cephalosporin-resistant Escherichia coli and Klebsiella account for case fatality rates between 12 and 52% in neonatal inpatients. Pan-resistance has been reported in 14–35.8% isolates of Acinetobacter spp. from developing country hospital inpatients over the last decade. Pseudomonas spp., an important neonatal killer in the Indo-Pak subcontinent, is ceftazidime resistant in 34–55% isolates and aminoglycoside resistant in 23–69% isolates. Alarmingly, these figures show a rising temporal trend and highlight antimicrobial-resistant organisms as major, untreatable threats in many resource-constrained countries. Antimicrobial resistance does not only mean increasing expense of treatment and poor clinical outcomes but also has a major impact on the way health systems are perceived and therefore accessed. There is an urgent need to devise comprehensive strategies and programs for improving hospital infection control and containing antimicrobial resistance in developing countries.


Antimicrobial Resistance Infection Control Program Hospital Infection Control Public Sector Hospital Nosocomial Infection Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Dr. Fatima Mir received research training support from the National Institute of Health’s Fogarty International Center (1 D43 TW007585-01) which made this work possible.


  1. Al-Otaibi, F.E., Kambal, A.M., and Baabbad, R.A. 2004. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia. Saudi. Med. J. 25: 21–25.PubMedGoogle Scholar
  2. Alp, E., Esel, D., Yildiz, O., Voss, A., Melchers, W., and Doganay, M. 2006. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital. Scand. J. Infect. Dis. 38: 335–340.CrossRefPubMedGoogle Scholar
  3. Archibald, L.K. and Reller, L.B. 2001. Clinical microbiology in developing countries. Emerg. Infect. Dis. 7: 302–305.CrossRefPubMedGoogle Scholar
  4. Austin, D.J., Bonten, M.J., Weinstein, R.A., Slaughter, S., and Anderson, R.M. 1999. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc. Natl. Acad. Sci. U.S.A 96: 6908–6913.CrossRefPubMedGoogle Scholar
  5. Baddour, M.M., Abuelkheir, M.M., Fatani, A.J., Bohol, M.F., and Al-Ahdal, M.N. 2007. Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from major hospitals in Riyadh, Saudi Arabia. Can. J. Microbiol. 53: 931–936.CrossRefPubMedGoogle Scholar
  6. Balkhy, H.H., Cunningham, G., Chew, F.K., Francis, C., Al Nakhli, D.J., Almuneef, M.A., and Memish, Z.A. 2006. Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int. J. Infect. Dis. 10: 326–333.CrossRefPubMedGoogle Scholar
  7. Bartoloni, A., Cutts, F., Leoni, S., Austin, C.C., Mantella, A., Guglielmetti, P., Roselli, M., Salazar, E., and Paradisi, F. 1998. Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. Trop. Med. Int. Health 3: 116–123.CrossRefPubMedGoogle Scholar
  8. Bello, H., Dominguez, M., Gonzalez, G., Zemelman, R., Mella, S., Young, H.K., and Amyes, S.G. 2000. In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998. J. Antimicrob. Chemother. 45: 712–713.CrossRefPubMedGoogle Scholar
  9. Bexell, A., Lwando, E., von, H.B., Tembo, S., Eriksson, B., and Diwan, V.K. 1996. Improving drug use through continuing education: a randomized controlled trial in Zambia. J. Clin. Epidemiol. 49: 355–357.CrossRefPubMedGoogle Scholar
  10. Boyce, J.M. 2007. Environmental contamination makes an important contribution to hospital infection. J. Hosp. Infect. 65 Suppl 2: 50–54.CrossRefPubMedGoogle Scholar
  11. Brusaferro, S., Regattin, L., Faruzzo, A., Grasso, A., Basile, M., Calligaris, L., Scudeller, L., and Viale, P. 2006. Surveillance of hospital-acquired infections: a model for settings with resource constraints. Am. J. Infect. Control 34: 362–366.CrossRefPubMedGoogle Scholar
  12. Coen, P.G. 2007. How mathematical models have helped to improve understanding the epidemiology of infection. Early Hum. Dev. 83: 141–148.CrossRefPubMedGoogle Scholar
  13. d'Azevedo, P.A., Dias, C.A., and Teixeira, L.M. 2006. Genetic diversity and antimicrobial resistance of enterococcal isolates from Southern region of Brazil. Rev. Inst. Med. Trop. Sao Paulo 48: 11–16.PubMedGoogle Scholar
  14. de Allori, M.C., Jure, M.A., Romero, C., and de Castillo, M.E. 2006. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol. Pharm. Bull. 29: 1592–1596.CrossRefPubMedGoogle Scholar
  15. Desta, Z., Abula, T., Beyene, L., Fantahun, M., Yohannes, A.G., and Ayalew, S. 1997. Assessment of rational drug use and prescribing in primary health care facilities in north west Ethiopia. East Afr. Med. J. 74: 758–763.PubMedGoogle Scholar
  16. Dimond, B. 2006. Infection control: the rights of the patient. Br. J. Nurs. 15: 670–671.PubMedGoogle Scholar
  17. Dineshkumar, B., Raghuram, T.C., Radhaiah, G., and Krishnaswamy, K. 1995. Profile of drug use in urban and rural India. Pharmacoeconomics 7: 332–346.CrossRefPubMedGoogle Scholar
  18. Duttaroy, B. and Mehta, S. 2005. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J. Pathol. Microbiol. 48: 45–48.PubMedGoogle Scholar
  19. Ejilemele, A.A. and Ojule, A.C. 2005. Knowledge, attitude and practice of aspects of laboratory safety in Pathology Laboratories at the University of Port Harcourt Teaching Hospital, Nigeria. Niger. J. Clin. Pract. 8: 102–106.PubMedGoogle Scholar
  20. Gaudiano, M.C., Di, M.A., Cocchieri, E., Antoniella, E., Bertocchi, P., Alimonti, S., and Valvo, L. 2007. Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials. Malar. J. 6: 22.CrossRefPubMedGoogle Scholar
  21. Geyid, A. and Lemeneh, Y. 1991. The incidence of methicillin resistant S. aureus strains in clinical specimens in relation to their beta-lactamase producing and multiple-drug resistance properties in Addis Abeba. Ethiop. Med. J. 29: 149–161.PubMedGoogle Scholar
  22. Grover, S.S., Sharma, M., Chattopadhya, D., Kapoor, H., Pasha, S.T., and Singh, G. 2006. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J. Infect. 53: 279–288.CrossRefPubMedGoogle Scholar
  23. Haddad, Q., Sobayo, E.I., Basit, O.B., and Rotimi, V.O. 1993. Outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. J. Hosp. Infect. 23: 211–222.CrossRefPubMedGoogle Scholar
  24. Hanssens, Y., Ismaeil, B.B., Kamha, A.A., Elshafie, S.S., Adheir, F.S., Saleh, T.M., and Deleu, D. 2005. Antibiotic prescribing pattern in a medical intensive care unit in Qatar. Saudi. Med. J. 26: 1269–1276.PubMedGoogle Scholar
  25. Harris, A.D., Perencevich, E.N., Johnson, J.K., Paterson, D.L., Morris, J.G., Strauss, S.M., and Johnson, J.A. 2007. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin. Infect. Dis. 45: 1347–1350.CrossRefPubMedGoogle Scholar
  26. Hart, C.A. and Kariuki, S. 1998. Antimicrobial resistance in developing countries. BMJ 317: 647–650.PubMedGoogle Scholar
  27. Harvey, K., Kalanj, K., and Stevanovic, R. 2004. Croatian pharmaceutical sector reform project: rational drug use. Croat. Med. J. 45: 611–619.PubMedGoogle Scholar
  28. Hogerzeil, H.V., Bimo, Ross-Degnan, D., Laing, R.O., Ofori-Adjei, D., Santoso, B., zad Chowdhury, A.K., Das, A.M., Kafle, K.K., Mabadeje, A.F., et al.. 1993. Field tests for rational drug use in twelve developing countries. Lancet 342: 1408–1410.CrossRefPubMedGoogle Scholar
  29. Jarvis, W.R. 2003. Benchmarking for prevention: the Centers for Disease Control and Prevention's National Nosocomial Infections Surveillance (NNIS) system experience. Infection 31 Suppl 2: 44–48.PubMedGoogle Scholar
  30. Jeena, P., Thompson, E., Nchabeleng, M., and Sturm, A. 2001. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies. Ann. Trop. Paediatr. 21: 245–251.CrossRefPubMedGoogle Scholar
  31. Jroundi, I., Khoudri, I., Azzouzi, A., Zeggwagh, A.A., Benbrahim, N.F., Hassouni, F., Oualine, M., and Abouqal, R. 2007. Prevalence of hospital-acquired infection in a Moroccan university hospital. Am. J. Infect. Control 35: 412–416.CrossRefPubMedGoogle Scholar
  32. Kanafani, Z.A., Kara, L., Hayek, S., and Kanj, S.S. 2003. Ventilator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms. Infect. Control Hosp. Epidemiol. 24: 864–869.CrossRefPubMedGoogle Scholar
  33. Kaushik, S.L., Parmar, V.R., Grover, N., Grover, P.S., and Kaushik, R. 1998. Neonatal sepsis in hospital born babies. J. Commun. Dis. 30: 147–152.PubMedGoogle Scholar
  34. Kesah, C., Ben, R.S., Odugbemi, T.O., Boye, C.S., Dosso, M., Ndinya Achola, J.O., Koulla-Shiro, S., Benbachir, M., Rahal, K., and Borg, M. 2003. Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin. Microbiol. Infect. 9: 153–156.CrossRefPubMedGoogle Scholar
  35. Kim, P.W., Roghmann, M.C., Perencevich, E.N., and Harris, A.D. 2003. Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites. Am. J. Infect. Control 31: 97–103.CrossRefPubMedGoogle Scholar
  36. Krishnan, P.U., Mahalakshmi, P., and Shetty, N. 2002. Strain relatedness of endemic MRSA isolates in a burns unit in South India––a five year study. J.Hosp.Infect. 52: 181–184.CrossRefPubMedGoogle Scholar
  37. Leblebicioglu, H., Rosenthal, V.D., Arikan, O.A., Ozgultekin, A., Yalcin, A.N., Koksal, I., Usluer, G., Sardan, Y.C., and Ulusoy, S. 2007. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J. Hosp. Infect. 65: 251–257.CrossRefPubMedGoogle Scholar
  38. Lopes, J.M., Starling, C.E., Lessa, C., and Couto, B.R. 1999. Joint effort to improve quality in a Brazilian pediatric public hospital through cross-infection control. J. Pediatr. (Rio J. ) 75: 361–366.Google Scholar
  39. Macias, A.E., Munoz, J.M., Herrera, L.E., Medina, H., Hernandez, I., Alcantar, D., and Ponce de, L.S. 2004. Nosocomial pediatric bacteremia: the role of intravenous set contamination in developing countries. Infect. Control Hosp. Epidemiol. 25: 226–230.CrossRefPubMedGoogle Scholar
  40. Macias, A.E. and Ponce-de-Leon, S. 2005. Infection control: old problems and new challenges. Arch. Med. Res. 36: 637–645.CrossRefPubMedGoogle Scholar
  41. Mallet, H.P., Njikam, A., and Scouflaire, S.M. 2001. Evaluation of prescription practices and of the rational use of medicines in Niger. Sante 11: 185–193.PubMedGoogle Scholar
  42. Mayon-White, R.T., Ducel, G., Kereselidze, T., and Tikomirov, E. 1988. An international survey of the prevalence of hospital-acquired infection. J. Hosp. Infect. 11 Suppl A: 43–48.CrossRefPubMedGoogle Scholar
  43. Meric, M., Willke, A., Caglayan, C., and Toker, K. 2005. Intensive care unit-acquired infections: incidence, risk factors and associated mortality in a Turkish university hospital. Jpn. J. Infect. Dis. 58: 297–302.PubMedGoogle Scholar
  44. Misbah, S., AbuBakar, S., Hassan, H., Hanifah, Y.A., and Yusof, M.Y. 2004. Antibiotic susceptibility and REP-PCR fingerprints of Acinetobacter spp. isolated from a hospital ten years apart. J. Hosp. Infect. 58: 254–261.CrossRefPubMedGoogle Scholar
  45. Mohanty, S., Singhal, R., Sood, S., Dhawan, B., Kapil, A., and Das, B.K. 2007. Citrobacter infections in a tertiary care hospital in Northern India. J. Infect. 54: 58–64.CrossRefPubMedGoogle Scholar
  46. Murray, B.E. 1992. Problems and dilemmas of antimicrobial resistance. Pharmacotherapy 12: 86S–93S.PubMedGoogle Scholar
  47. Naeem, I., Naqvi, B.S., Hashmi, K., and Gauhar, S. 2006. Paediatric nosocomial infections: resistance pattern of clinical isolates. Pak. J. Pharm. Sci. 19: 52–57.PubMedGoogle Scholar
  48. Nathoo, K.J., Mason, P.R., and Chimbira, T.H. 1990. Neonatal septicaemia in Harare Hospital: aetiology and risk factors. The Puerperal Sepsis Study Group. Cent. Afr. J. Med. 36: 150–156.PubMedGoogle Scholar
  49. Norazah, A., Lim, V.K., Rohani, M.Y., Alfizah, H., Koh, Y.T., and Kamel, A.G. 2003. A major methicillin-resistant Staphylococcus aureus clone predominates in Malaysian hospitals. Epidemiol. Infect. 130: 407–411.CrossRefPubMedGoogle Scholar
  50. Nyamogoba, H. and Obala, A.A. 2002. Nosocomial infections in developing countries: cost effective control and prevention. East Afr. Med. J. 79: 435–441.PubMedGoogle Scholar
  51. Oncul, O., Yuksel, F., Altunay, H., Acikel, C., Celikoz, B., and Cavuslu, S. 2002. The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey. Burns 28: 738–744.CrossRefPubMedGoogle Scholar
  52. Orrett, F.A. 2005. Clinical sources and prevalence of resistance to antimicrobials of Klebsiella pneumoniae strains in Trinidad. Saudi. Med. J. 26: 1766–1770.PubMedGoogle Scholar
  53. Ota, R., Takahashi, C., Shiraishi, T., and Tominaga, M. 2007. Genesis of methicillin-resistant Staphylococcus aureus and selective antibacterial injection pressure. Kansenshogaku Zasshi 81: 370–378.PubMedGoogle Scholar
  54. Panknin, H.T. 2006. Prevention of ventilator-associated pneumonia: review of national and international guidelines. Pflege. Z. 59: suppl-8.Google Scholar
  55. Pearse, J. 1997. Infection control in Africa. Nosocomial infection. Afr. Health 19: 10–11.Google Scholar
  56. Perdelli, F., Dallera, M., Cristina, M.L., Sartini, M., Ottria, G., Spagnolo, A.M., and Orlando, P. 2007. A new microbiological problem in intensive care units: environmental contamination by MRSA with reduced susceptibility to glycopeptides. Int. J. Hyg. Environ. Health 211(1–2):213–218.PubMedGoogle Scholar
  57. Perovic, O., Koornhof, H., Black, V., Moodley, I., Duse, A., and Galpin, J. 2006. Staphylococcus aureus bacteraemia at two academic hospitals in Johannesburg. S. Afr. Med. J. 96: 714–717.PubMedGoogle Scholar
  58. Perwaiz, S., Barakzi, Q., Farooqi, B.J., Khursheed, N., and Sabir, N. 2007. Antimicrobial susceptibility pattern of clinical isolates of methicillin resistant Staphylococcus aureus. J. Pak. Med. Assoc. 57: 2–4.PubMedGoogle Scholar
  59. Ponce-de-Leon, S. 1991. The needs of developing countries and the resources required. J. Hosp. Infect. 18 Suppl A: 376–381.CrossRefPubMedGoogle Scholar
  60. Pottinger J.M., Herwaldt L.A., and Perl T.M. 1998. Basics of Surveillance-an overview. In A Practical Handbook for Hospital Epidemiologists. The Society for Healthcare Epidemiology of America. SLACK Incorporated and SHEA.Google Scholar
  61. Prashanth, K. and Badrinath, S. 2005. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR & pulse field gel electrophoresis. Indian J. Med. Res. 122: 408–418.PubMedGoogle Scholar
  62. Qadri, S.M., Huber, T.W., Lee, G.C., and al-Hajjar, S. 1994. Antimicrobial resistance of bacterial pathogens at two tertiary-care centers, in Riyadh and Texas. Tex. Med. 90: 59–62.PubMedGoogle Scholar
  63. Ramdani-Bouguessa, N., Bes, M., Meugnier, H., Forey, F., Reverdy, M.E., Lina, G., Vandenesch, F., Tazir, M., and Etienne, J. 2006. Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital. Antimicrob. Agents Chemother. 50: 1083–1085.CrossRefPubMedGoogle Scholar
  64. Rhinehart, E., Goldmann, D.A., and O'Rourke, E.J. 1991. Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am. J. Med. 91: 213S–220S.CrossRefPubMedGoogle Scholar
  65. Ribas, R.M., Freitas, C., and Gontijo Filho, P.P. 2007. Nosocomial bloodstream infections: organisms, risk factors and resistant phenotypes in the Brazilian University Hospital. Braz. J. Infect. Dis. 11: 351–354.PubMedGoogle Scholar
  66. Romero, D.V., Treston, J., and O'Sullivan, A.L. 2006. Hand-to-hand combat: preventing MRSA infection. Adv. Skin Wound Care 19: 328–33, quiz.CrossRefPubMedGoogle Scholar
  67. Rosenthal, V.D., Guzman, S., and Orellano, P.W. 2003. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am. J. Infect. Control 31: 291–295.CrossRefPubMedGoogle Scholar
  68. Rosenthal, V.D., Maki, D.G., Salomao, R., Moreno, C.A., Mehta, Y., Higuera, F., Cuellar, L.E., Arikan, O.A., Abouqal, R., and Leblebicioglu, H. 2006. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann. Intern. Med. 145: 582–591.PubMedGoogle Scholar
  69. Saez-Llorens, X., Castrejon de Wong, M.M., Castano, E., De, S.O., De, M.D., and De, A., I .2000. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. Pediatr. Infect. Dis. J. 19: 200–206.Google Scholar
  70. Safdar, N. and Maki, D.G. 2002. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann. Intern. Med. 136: 834–844.PubMedGoogle Scholar
  71. Selgelid, M.J. 2005. Ethics and infectious disease. Bioethics 19: 272–289.CrossRefPubMedGoogle Scholar
  72. Shehabi, A.A., Mahafzah, A.M., and Al-Khalili, K.Z. 2004. Antimicrobial resistance and plasmid profiles of urinary Escherichia coli isolates from Jordanian patients. East Mediterr. Health J. 10: 322–328.PubMedGoogle Scholar
  73. Soleto, L., Pirard, M., Boelaert, M., Peredo, R., Vargas, R., Gianella, A., and Van der, S.P. 2003. Incidence of surgical-site infections and the validity of the National Nosocomial Infections Surveillance System risk index in a general surgical ward in Santa Cruz, Bolivia. Infect. Control Hosp. Epidemiol. 24: 26–30.CrossRefPubMedGoogle Scholar
  74. Szeto, C.C., Chow, K.M., Kwan, B.C., Law, M.C., Chung, K.Y., Yu, S., Leung, C.B., and Li, P.K. 2007. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin. J. Am. Soc. Nephrol. 2: 245–251.CrossRefPubMedGoogle Scholar
  75. Tateda, K. 2002. From the perspective of clinical laboratory physicians. Rinsho Byori 50: 672–677.PubMedGoogle Scholar
  76. Torres, A. 2006. The new American Thoracic Society/Infectious Disease Society of North America guidelines for the management of hospital-acquired, ventilator-associated and healthcare-associated pneumonia: a current view and new complementary information. Curr. Opin. Crit. Care 12(5):444–445.CrossRefPubMedGoogle Scholar
  77. Urdea, M., Penny, L.A., Olmsted, S.S., Giovanni, M.Y., Kaspar, P., Shepherd, A., Wilson, P., Dahl, C.A., Buchsbaum, S., Moeller, G., and Hay, B. 2006. Requirements for high impact diagnostics in the developing world. Nature 444 Suppl 1: 73–79.CrossRefPubMedGoogle Scholar
  78. Vidhani, S., Mehndiratta, P.L., and Mathur, M.D. 2001. Study of methicillin resistant S. aureus (MRSA) isolates from high risk patients. Indian J. Med. Microbiol. 19: 13–16.PubMedGoogle Scholar
  79. vila-Figueroa, C., Cashat-Cruz, M., randa-Patron, E., Leon, A.R., Justiniani, N., Perez-Ricardez, L., vila-Cortes, F., Castelan, M., Becerril, R., and Herrera, E.L. 1999. Prevalence of nosocomial infections in children: survey of 21 hospitals in Mexico. Salud Publica Mex. 41 Suppl 1: S18–S25.Google Scholar
  80. Vincent, J.L., Brun-Buisson, C., Niederman, M., Haenni, C., Harbarth, S., Sprumont, D., Valencia, M., and Torres, A. 2005. Ethics roundtable debate: a patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus – how do you defend your case and your team? Crit Care 9: 5–9.CrossRefPubMedGoogle Scholar
  81. Wertheimer, A.I. and Santella, T.M. 2007. Innovation and the WHO's essential medicines list: giving credit where credit is due. Res. Social. Adm Pharm. 3: 137–144.PubMedGoogle Scholar
  82. WHO and UNICEF. Management of the child with a serious illness or severe malnutrition. Guidelines for care at the first referral level in developing countries. WHO/FCH/CAH/00.1.2000. Geneva: World Health Organization, 2000.Google Scholar
  83. Yalcin, A.N. 2003. Socioeconomic burden of nosocomial infections. Indian J. Med. Sci. 57: 450–456.PubMedGoogle Scholar
  84. Yang, K.S., Fong, Y.T., Lee, H.Y., Kurup, A., Koh, T.H., Koh, D., and Lim, M.K. 2007. Predictors of vancomycin-resistant enterococcus (VRE) carriage in the first major VRE outbreak in Singapore. Ann. Acad. Med. Singapore 36: 379–383.PubMedGoogle Scholar
  85. Zaidi, A.K., Huskins, W.C., Thaver, D., Bhutta, Z.A., Abbas, Z., and Goldmann, D.A. 2005. Hospital-acquired neonatal infections in developing countries. Lancet 365: 1175–1188.CrossRefPubMedGoogle Scholar
  86. Zaidi, M., Angulo, M., and Sifuentes-Osornio, J. 1995. Disinfection and sterilization practices in Mexico. J. Hosp. Infect. 31: 25–32.CrossRefPubMedGoogle Scholar
  87. Zarate, M.S., Gales, A., Jorda-Vargas, L., Yahni, D., Relloso, S., Bonvehi, P., Monteiro, J., Campos-Pignatari, A., and Smayevsky, J. 2007. Environmental contamination during a vancomycin-resistant Enterococci outbreak at a hospital in Argentina. Enferm. Infecc. Microbiol. Clin. 25: 508–512.CrossRefPubMedGoogle Scholar
  88. Zavascki, A.P., Barth, A.L., Gaspareto, P.B., Goncalves, A.L., Moro, A.L., Fernandes, J.F., and Goldani, L.Z. 2006. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J. Antimicrob. Chemother. 58: 882–885.CrossRefPubMedGoogle Scholar
  89. Zubaidah, A.W., Ariza, A., and Azmi, S. 2006. Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital. Med. J. Malaysia 61: 487–489.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Paediatrics and Child HealthAga Khan UniversityKarachiPakistan

Personalised recommendations